dissolvable semaglutide Oral | Starts at $249/mo Semaglutide Sublingual 1mg/ml | NextGenRx

Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes

Dose attenuation is required to allow for milder and more gradual weight loss to mitigate the effects of weight-loss-related sarcopenia

Indicators of kidney damage include: Less frequent urination Fatigue Shortness of breath Nausea Chest Pain Kidney damage can have serious long-term effects on a person

Important safety considerations include caution in patients with diabetic retinopathy, particularly with semaglutide, as rapid improvement in glucose control may temporarily worsen retinopathy

Doctors are beginning to prescribe GLP-1s for younger children, but its off-label, meaning the drug hasnt been formally tested and approved for that age group

Rising GLP-1 use creates opportunity for natural dietary supplement retailers As prescription medications such as Ozempic grow in popularity, retailers can support consumers with needed supplements or natural alternatives